NCT02890472 is a clinical trial in 22q11 Deletion Syndrome Di George Syndrome, sponsored by Centre Hospitalier Universitaire de Nīmes.

Who is sponsoring NCT02890472?

NCT02890472 is sponsored by Centre Hospitalier Universitaire de Nīmes.

What condition does NCT02890472 study?

NCT02890472 studies 22q11 Deletion Syndrome Di George Syndrome.

Is NCT02890472 still recruiting?

NCT02890472 is currently completed. Last updated 27 January 2021.

Last reviewed 2021-01-27 · How we verify

NCT02890472

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prenatal Examination of Deletion 22q11 Syndrome : Thymic Dysgenesis THYMI Study

Completed Last updated 27 January 2021

What this trial tests

trial in 22q11 Deletion Syndrome Di George Syndrome in 13 participants. Completed in 31 December 2020.

Timeline

1 October 2017

Primary endpoint
1 July 2020

31 December 2020

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nīmes
Status	Completed
Study type	OBSERVATIONAL
Enrollment	13
Start date	1 October 2017
Primary completion	1 July 2020
Estimated completion	31 December 2020
Sites	1 location across France

Conditions studied

22q11 Deletion Syndrome Di George Syndrome — all drugs for 22q11 Deletion Syndrome Di George Syndrome →

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

18 and older, female only, with 22q11 Deletion Syndrome Di George Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

22q11.2 microdeletion seems the prenatally under-diagnosed . Indeed , there is a mismatch between the series on the heart rate of 22q11.2 antenatal 84% against 30% in the adult series despite a perinatal mortality of 16% suggesting opportunities for improvement in the prenatal diagnosis of fetus with a microdeletion 22q11.2 , especially without heart disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

NCT07403474 — Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Ther · Phase 4 · not yet recruiting
NCT07455981 — Work Organization and Gambling Addiction · not yet recruiting
NCT07403500 — Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain. · NA · not yet recruiting
NCT07342010 — Bicarbonate Addition to Lidocaine-Epinephrine in Surgery Under WALANT · Phase 4 · not yet recruiting
NCT07305727 — A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02890472 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nīmes
Last refreshed: 27 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02890472.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing